FBXW7 Reduces the Cancer Stem Cell-Like Properties of Hepatocellular Carcinoma by Regulating the Ubiquitination and Degradation of ACTL6A

Investigators found that FBXW7 participated in the self-renewal, tumorigenicity, sorafenib therapy, and stem cell-like properties of hepatocellular carcinoma cells in vivo and in vitro.